We upgrade DAGRI to BUY (from Accumulate) with revised target price of Rs 953 (Previous 868) based on 18x FY23 EPS of Rs 53 as we roll forward to FY23 estimates. We have also increased our PAT estimates for FY21-23 by 4-5%. DAGRI reported better than expected EBITDA growth of 46% to Rs 502 mn (PLe Rs 405 mn) driven by better sales mix and sharp growth in fungicides segment. Q4 is expected to be another good quarter driven by demand, due to deferment of season from Q3 and low base effect due to lockdown in Q4....